tiprankstipranks
Xeris Pharmaceuticals (DE:2B30)
NASDAQ:2B30
Germany Market

Xeris Pharmaceuticals (2B30) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Xeris Pharmaceuticals’s (2B30) Moving Averages Convergence Divergence (MACD) indicator is 0.40, suggesting Xeris Pharmaceuticals is a Buy.
Xeris Pharmaceuticals’s (2B30) 20-Day exponential moving average is 7.02, while Xeris Pharmaceuticals’s (2B30) share price is €5.12, making it a Buy.
Xeris Pharmaceuticals’s (2B30) 50-Day exponential moving average is 6.37, while Xeris Pharmaceuticals’s (2B30) share price is €5.12, making it a Buy.

Xeris Pharmaceuticals (2B30) Pivot Points

Jul 24, 2026, 11:51 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.56
7.56
7.56
7.56
7.56
7.56
7.56
Fibonacci
7.56
7.56
7.56
7.56
7.56
7.56
7.56
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Xeris Pharmaceuticals (2B30) Moving Averages

Jul 24, 2026, 11:51 PM
Period
Simple
Exponential
MA5
7.40Buy
7.40Sell
MA10
7.38Buy
7.30Buy
MA20
7.07Buy
7.02Buy
MA50
6.09Buy
6.37Buy
MA100
5.56Buy
6.01Buy
MA200
5.99Buy
6.07Buy
Xeris Pharmaceuticals’s (2B30) 10-Day exponential moving average is 7.30, while Xeris Pharmaceuticals’s (2B30) share price is €5.12, making it a Buy.
Xeris Pharmaceuticals’s (2B30) 100-Day exponential moving average is 6.01, while Xeris Pharmaceuticals’s (2B30) share price is €5.12, making it a Buy.
Xeris Pharmaceuticals’s (2B30) stock price is €5.12 and Xeris Pharmaceuticals’s (2B30) 50-day simple moving average is 6.09, creating a Buy signal.
Xeris Pharmaceuticals’s (2B30) stock price is €5.12 and Xeris Pharmaceuticals’s (2B30) 100-day simple moving average is 5.56, creating a Buy signal.
Xeris Pharmaceuticals’s (2B30) stock price is €5.12 and Xeris Pharmaceuticals’s (2B30) 200-day simple moving average is 5.99, creating a Buy signal.

Xeris Pharmaceuticals (2B30) Technical Indicators

Jul 24, 2026, 11:51 PM
Name
Value
Implied Action
RSI (14)
65.37
Neutral
STOCH (9,6)
72.22
Neutral
STOCHRSI (14)
73.81
Neutral
MACD (12,26)
0.40
Buy
ADX (14)
42.81
Neutral
Williams %R
-37.66
Buy
CCI (14)
63.43
Neutral
ATR (14)
0.15
-
Ultimate Oscillator
55.13
Neutral
ROC
8.41
Buy
Xeris Pharmaceuticals’s (2B30) Relative Strength Index (RSI) is 65.37, creating a Neutral signal.
Xeris Pharmaceuticals’s (2B30) Trend Strength Indicator (ADX) is 42.81, creating a Neutral signal.
Xeris Pharmaceuticals’s (2B30) Commodity Channel Index (CCI) is 63.43, creating a Neutral signal.
Xeris Pharmaceuticals’s (2B30) Price Rate of Change (ROC) is 8.41, creating a Buy signal.

FAQ

Is 2B30 a Buy, Hold, or Sell?
Based on 2B30’s technical indicators, 2B30 is a Strong Buy.
    What is 2B30’s RSI (14)?
    2B30’s RSI (14) is 65.37, which suggests 2B30 is a Neutral.
      What is 2B30’s MACD?
      2B30’s MACD is 0.40, which suggests 2B30 is a Buy.
        What is 2B30’s 5-day moving average?
        2B30’s 5-day moving average is 7.40, which suggests 2B30 is a Buy.
          What is 2B30’s 20-day moving average?
          2B30 20-day moving average is 7.07, which suggests 2B30 is a Buy.
            What is 2B30’s 50-day moving average?
            2B30’s 50-day moving average is 6.09, which suggests 2B30 is a Buy.
              What is 2B30’s 200-day moving average?
              2B30’s 200-day moving average is 5.99, which suggests 2B30 is a Buy.
                What is 2B30’s Williams % R (14)?
                2B30’s Williams % R (14) is -37.66, which suggests 2B30 is a Buy.
                  What is 2B30’s CCI (14)?
                  2B30’s CCI (14) is 63.43, which suggests 2B30 is a Neutral.
                    What is the share price of Xeris Pharmaceuticals?